Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Noguchi Shinohara, Moeko ^a   Yuki, Sohshi ^a   Dohmoto, Chiaki ^a   Ikeda, Yoshihisa ^a   Samuraki, Miharu ^a   Iwasa, Kazuo ^a   Yokogawa, Masami ^a   Asai, Kimiko ^b   Komai, Kiyonobu ^c   Nakamura, Hiroyuki ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Bishoen Geriatric Health Services Facility   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL EVALUATION; CLINICAL TRIAL; COFFEE; COGNITIVE DEFECT; DEMENTIA; DIETARY INTAKE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; JAPAN; JAPANESE (PEOPLE); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPROTECTION; NUTRITIONAL ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; RISK REDUCTION; TEA; THERAPY EFFECT; DRINKING; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; RISK; VERY ELDERLY;

COFFEE; TEA;

AGED; AGED, 80 AND OVER; COFFEE; DEMENTIA; DRINKING; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PROSPECTIVE STUDIES; RISK; TEA;

EID: 84901346153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096013     Document Type: Article

References (39)

1. Levites Y, Weinreb O, Maor G, Youdim MBH, Mandel S (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 377:1073-1082. (Pubitemid 32823156)
2. Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, et al. (2001) The green tea polyphenol (-)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70:603-614. (Pubitemid 34082702)
3. Levites Y, Amit T, Mandel S, Youdim MBH (2003) Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidgenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 17:952-954.
4. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, et al. (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 87:172-181. (Pubitemid 37210651)
5. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, et al. (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214:177-187.
6. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, et al. (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807-8814. (Pubitemid 41362059)
7. Ho L, Varghese M, Wang J, Zhao W, Chen F, et al. (2012) Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutr Neurosci 15: 37-45.
8. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, et al. (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 142:941-952. (Pubitemid 44740473)
9. Dall'Inga OP, Fett P, Gomes MW, Souza DO, Cunha RA, et al. (2007) Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203:241-245. (Pubitemid 44821181)
10. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, et al. (2002) Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156:445-453. (Pubitemid 34976983)
11. Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, et al. (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study. Eur J Clin Nutr 61:226-232.
12. Ritchie K, Carriere I, Mendonca A, Portet F, Dartigues JF, et al. (2007) The neuroprotective effects of caffeine. A prospective population study (the Three City Study). Neurology 69:536-545. (Pubitemid 47357260)
13. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study. J Alzheimers Dis 16:85-91.
14. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia. The Honolulu-Asia Aging Study. Am J Epidemiol 159:959-967. (Pubitemid 38608273)
15. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB (2006) Fruit and vegetable juices and Alzheimer's disease: The Kame project. Am J Med 119:751-759. (Pubitemid 44308471)
16. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, et al. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. Am J Clin Nutr 83:355-61. (Pubitemid 44713198)
17. Sugano K, Yokogawa M, Yuki S, Dohmoto C, Yoshita M, et al. (2012) Effect of cognitive and aerobic training intervention on older adults with mild or no cognitive impairment: a derivative study of the Nakajima Project. Dement Geriatr Cogn Disord Extra 2:69-80.
18. Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, et al. (2013) Differences in the prevalence of dementia and mild cognitive impairment and cognitive functions between early and delayed responders in a community-based study of the elderly. J Alzheimers Dis 37: 691-698.
19. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12:189-198.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572. (Pubitemid 12124384)
21. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43:2411-2413.
22. Morris JC, Storandt M, Miller JP, McKeel DW, Prince JL, et al. (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397-405. (Pubitemid 32217456)
23. Lykkesfeldt J, Loft S, Poulsen HE (1995) Determination of ascorbic acid dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-are they reliable biomarkers of oxidative stress? Anal Biochem 229:329-335.
24. Kamboh MI, Ferrel RE, Kottke B (1998) Genetic studies of human apolipoproteins V: a novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 29:1535-1543.
25. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 3rd ed, revised. Washington DC: Amerian Psychiatric Association.
26. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiqlioni L, et al. (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 256:240-246. (Pubitemid 39222993)
27. Peterson J, Dwyer J, Bhagwat S, Haytowitz D, Holden J, et al. (2005) Major flavonoids in dry tea. J Food Compost Anal 18:487-501. (Pubitemid 40277329)
28. Nakagawa K, Miyazawa T (1997) Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol 43:679-684. (Pubitemid 28045726)
29. Bastianetto S, Yao ZX, Papadopoulos V, Quirion R (2006) Neuroprotective effects of green and black teas and their catechin gallate esters against β-amyloid-induced toxicity. Eur J Neurosci 23:55-64.
30. Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, et al. (2012) Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site specific binding. J Biol Chem 2012;287:14631-14643.
31. Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenoic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway. Am J Pathol 175:2557-2565.
32. Barone JJ, Roberts HR (1996) Caffeine consumption. Food Cham Toxicol. 34:119-129. (Pubitemid 26057854)
33. Khokhar S, Magnusdottir SGM (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50:565-570. (Pubitemid 34106679)
34. Engelhart MJ, Geerlings MI, Ruitenberg A, Swieten JC, Hofman A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223-3229. (Pubitemid 34686103)
35. Ogawa K, Tsubono Y, Nishino Y, Watanabe Y, Ohkubo T, et al. (2002) Dietary sources of nutrient consumption in a rural Japanese population. J Epidemiol 12:1-8. (Pubitemid 44004190)
36. Science and Technology Agency (2010) Standard tables of food composition in Japan 2010. [on line] Available: www.mext.go.jp/b-menu/shingi/gijyutu/ gijyutu3/houkoku/1298713.htm (in Japanese). Accessed 2013 Aug 16.
37. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, et al. (2009) L-Theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kB pathways. Free Radic Biol Med 47:1601-1610.
38. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, et al. (2012) Association of lifetime cognitive engagement and low β-amyloid deposition. Arch Neurol 69:623-629.
39. Bruijin RFG, Schrijvers EMC, Groot KA, Witteman JC, Hofman A, et al. (2013) The association between physical activity and dementia in an elderly population: the Rotterdam study. Eur J Epidemiol 28:277-283.